<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">Using in vitro drug screen data from ConnectivityMap
 <sup>
  <xref ref-type="bibr" rid="CR17">17</xref>
 </sup>, we identified 19 compounds that induced strong opposing gene expression signatures, reducing the expression of genes with cross-omics higher expression in high-grade cartilage (Table 
 <xref rid="Tab2" ref-type="table">2</xref>, Supplementary Data 
 <xref rid="MOESM10" ref-type="media">6</xref>, and Supplementary Note 
 <xref rid="MOESM1" ref-type="media">6</xref>). Several of these compounds foster known biological relevance to osteoarthritis, including the oestrogen receptor agonists diethylstilbestrol and alpha-estradiol, consistent with established epidemiological data showing an association between osteoarthritis and oestrogen deficiency
 <sup>
  <xref ref-type="bibr" rid="CR18">18</xref>
 </sup>. Although studies of oestrogen therapy for osteoarthritis have been inconclusive
 <sup>
  <xref ref-type="bibr" rid="CR19">19</xref>,
  <xref ref-type="bibr" rid="CR20">20</xref>
 </sup>, this screening approach could facilitate further refinement of existing drug groups and allow more focussed investigational molecule development.
</p>
